School of Medicine, University of Glasgow, Glasgow, UK.
Department of Otolaryngology-Head and Neck Surgery, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK.
Eur Arch Otorhinolaryngol. 2022 Oct;279(10):4825-4830. doi: 10.1007/s00405-022-07281-2. Epub 2022 Feb 7.
To determine the long-term outcomes of patients with vestibular schwannomas (VS) after stereotactic radiosurgery (SRS) who experience delayed tumour regrowth.
We carried out a retrospective case series in tertiary university settings. We included patients with VS with initial response to SRS and delayed regrowth, assessing a database of 735 patients with VS and 159 patients who had SRS as sole treatment. Following SRS, all patients had clinical follow-up and serial magnetic resonance imaging (MRI). We documented the post-SRS clinical assessment, pre- and post-SRS VS size as per MRI in predetermined time periods, response to treatment and rate of (re-) growth and the final outcome in each case.
We identified six patients with good initial response but delayed VS regrowth at a faster rate than pre-SRS. The mean growth rate for these VS was 0.347 mm/month (range 0.04-0.78 mm/month) prior to treatment; the mean growth rate at the time of delayed re-growth was 0.48 mm/month (range 0.17-0.75 mm/month); this did not reach the level of statistical significance (p = 0.08). This regrowth occurred at a mean time of 42 months (range 36-66 months) post-SRS and stopped 22 months (mean, range 12-36 months) post regrowth detection in all cases.
Given that delayed post-SRS VS regrowth can occur in approximately 4% of the treated cases, it is important to continue close clinical and radiological follow-up. Despite this abnormal behaviour, VS do stop growing again; still, patients should be made aware of the possibility of this uncommon VS behaviour following SRS.
确定经历立体定向放射外科(SRS)后肿瘤延迟生长的前庭神经鞘瘤(VS)患者的长期结果。
我们在三级大学环境中进行了回顾性病例系列研究。我们纳入了初始 SRS 反应良好但出现延迟肿瘤生长的 VS 患者,评估了 735 例 VS 患者和 159 例 SRS 作为唯一治疗方法的患者数据库。SRS 后,所有患者均进行临床随访和连续磁共振成像(MRI)检查。我们记录了 SRS 后的临床评估、SRS 前后 MRI 确定的 VS 大小、治疗反应、(再)生长率和每种情况下的最终结果。
我们发现 6 例患者初始反应良好,但 VS 延迟生长速度比 SRS 前更快。这些 VS 的平均生长率在治疗前为 0.347mm/月(范围为 0.04-0.78mm/月);延迟再生长时的平均生长率为 0.48mm/月(范围为 0.17-0.75mm/月);但这并未达到统计学意义(p=0.08)。这种生长发生在 SRS 后平均 42 个月(范围 36-66 个月),在所有病例中,在检测到再生长后 22 个月(平均 12-36 个月)停止生长。
鉴于大约 4%的治疗病例可能会出现 SRS 后 VS 延迟生长,因此继续进行密切的临床和放射学随访非常重要。尽管出现这种异常行为,但 VS 确实会再次停止生长;尽管如此,仍应让患者意识到 SRS 后这种罕见的 VS 行为的可能性。